As of 2026-01-07, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (28.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -2342.6%.
The range of the Relative Valuation is (29.60) - (29.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.1x - 34.2x | 31.1x |
| Forward P/E multiples | 27.6x - 30.5x | 29.7x |
| Fair Price | (29.60) - (29.02) | (28.93) |
| Upside | -2394.2% - -2349.9% | -2342.6% |
| Date | P/E |